Obesity Drugs: Jury's Still Out On Potential US Health Care Savings, CBO Says
The Congressional Budget Office’s perception of the limits of current data on the broader health benefits of anti-obesity medications highlights the challenges facing legislation enabling Medicare coverage for the drugs.
